APOA5 Antikörper
-
- Target Alle APOA5 Antikörper anzeigen
- APOA5 (Apolipoprotein A-V (APOA5))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOA5 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human APOA5 (NP_443200.2).
- Isotyp
- IgG
- Top Product
- Discover our top product APOA5 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- APOA5 (Apolipoprotein A-V (APOA5))
- Andere Bezeichnung
- APOA5 (APOA5 Produkte)
- Hintergrund
- The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.
- Gen-ID
- 116519
- UniProt
- Q6Q788
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
-